LENZ Therapeutics (LENZ) Interest Coverage Ratio (2020 - 2026)
LENZ Therapeutics' (LENZ) quarterly Interest Coverage Ratio came in at 61.64 in Q1 2026, down 372.93% year-on-year from 22.58 in Q1 2025, and up 95.51% on a QoQ basis from 1373.68 in Q4 2025.
LENZ Therapeutics (LENZ) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
LENZ Therapeutics (LENZ) has 7 years of Interest Coverage Ratio data on file, last reported at 61.64 in Q1 2026.
- On a quarterly basis, Interest Coverage Ratio fell 372.93% year-over-year to 61.64 in Q1 2026; TTM through Mar 2026 was 165.28, a 261.13% decrease from a year earlier, with the FY2025 full-year figure at 1.3, down 22.83% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 61.64, up from 1373.68 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for LENZ reached as high as 5.41 in Q4 2023 and fell as low as 1373.68 in Q4 2025.
- Historically, Interest Coverage Ratio has averaged 113.22 across 5 years, with a median of 8.56 in 2024.
- Across the five-year window, Interest Coverage Ratio surged 143.36% in 2023 and plunged 500929.52% in 2025, its largest moves.
- Year by year, Interest Coverage Ratio stood at 12.48 in 2022, then jumped by 143.36% to 5.41 in 2023, then plunged by 105.07% to 0.27 in 2024, then plunged by 500929.52% to 1373.68 in 2025, then surged by 95.51% to 61.64 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 61.64 in Q1 2026, 1373.68 in Q4 2025, and 18.35 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | LENZ Therapeutics | 158.34 Mn | 158.34 Mn | 825,000.00 | -61.64 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -61.64 |
| Dec 31, 2025 | -1,373.68 |
| Sep 30, 2025 | -18.35 |
| Jun 30, 2025 | -14.71 |
| Mar 31, 2025 | -13.03 |
| Dec 31, 2024 | -0.27 |
| Sep 30, 2024 | -8.09 |
| Jun 30, 2024 | -8.56 |
| Mar 31, 2024 | -392.39 |
| Dec 31, 2023 | 5.41 |
| Sep 30, 2023 | -0.60 |
| Jun 30, 2023 | -0.43 |
| Mar 31, 2023 | -2.62 |
| Dec 31, 2022 | -12.48 |
| Sep 30, 2022 | -3.48 |
| Jun 30, 2022 | -0.04 |
| Mar 31, 2022 | -19.71 |
| Dec 31, 2021 | -9.45 |
| Sep 30, 2021 | -0.36 |
| Jun 30, 2021 | -0.16 |